Some drugmakers seeking to make opposition against drug price cut plan

Published: 2011-12-26 07:00:00

Updated: 2011-12-26 07:00:00

Some Korean drug firms are poised to make an opposition against the government’s policy to slash drug prices next year amid the planned lawsuit led by the Korea Pharmaceutical Manufacturers Association.

More recently, the Health Insurance Review and Assessment Service published a list of insur...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK